These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32972546)

  • 121. Efficacy of intra-operative radiofrequency ablation in patients with permanent atrial fibrillation undergoing concomitant mitral valve replacement.
    Myrdko T; Sniezek-Maciejewska M; Rudziński P; Myć J; Lelakowski J; Majewski J
    Kardiol Pol; 2008 Sep; 66(9):932-8; discussion 939-40. PubMed ID: 18924020
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Early management of atrial fibrillation to prevent cardiovascular complications.
    Nattel S; Guasch E; Savelieva I; Cosio FG; Valverde I; Halperin JL; Conroy JM; Al-Khatib SM; Hess PL; Kirchhof P; De Bono J; Lip GY; Banerjee A; Ruskin J; Blendea D; Camm AJ
    Eur Heart J; 2014 Jun; 35(22):1448-56. PubMed ID: 24536084
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy.
    Barbhaiya CR; Kumar S; Baldinger SH; Michaud GF; Stevenson WG; Falk R; John RM
    Heart Rhythm; 2016 Feb; 13(2):383-90. PubMed ID: 26400855
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure.
    Suman-Horduna I; Roy D; Frasure-Smith N; Talajic M; Lespérance F; Blondeau L; Dorian P; Khairy P;
    J Am Coll Cardiol; 2013 Jan; 61(4):455-460. PubMed ID: 23265334
    [TBL] [Abstract][Full Text] [Related]  

  • 125. [Echocardiographic factors predictive of restoration and maintenance of sinus rhythm after reduction of atrial fibrillation].
    Ben Khalfallah A; Sanaa I
    Arch Mal Coeur Vaiss; 2007 Sep; 100(9):745-52. PubMed ID: 18033001
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion.
    Kang JH; Lee DI; Kim S; Kim MN; Park YM; Ban JE; Choi JI; Lim HE; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1165-70. PubMed ID: 22882453
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Predictors of developing renal dysfunction following diagnosis of transthyretin cardiac amyloidosis.
    McDonald ML; Manla Y; Sonnino A; Alonso M; Neicheril RK; Sanchez A; Lafave G; Armas YS; Camargo AL; Uppal D; Handa A; Wolinsky D; Rivera NT; Velez M; Baran DA; Estep JD; Snipelisky D
    Clin Cardiol; 2024 Jun; 47(6):e24298. PubMed ID: 38873847
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates.
    Aquaro GD; Morini S; Grigoratos C; Taborchi G; Di Bella G; Martone R; Vignini E; Emdin M; Olivotto I; Perfetto F; Cappelli F
    Int J Cardiol Heart Vasc; 2020 Dec; 31():100633. PubMed ID: 32995476
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Prevalence and characteristics of patients with incidental cardiac uptake on bone scintigraphy.
    Son J; Han YH; Lee SH
    J Cardiovasc Imaging; 2024 Aug; 32(1):19. PubMed ID: 39095877
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network.
    Choy CH; Steeds RP; Pinney J; Baig S; Turvey-Haigh L; Wahid Y; Cox H; Zaphiriou A; Srinivasan V; Wilson D; Fryearson J; Ahamed M; Lim S; Chue C; Pratt G; Fontana M; Gillmore JD; Moody WE
    Clin Med (Lond); 2024 Jan; 24(1):100004. PubMed ID: 38377730
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies.
    Porcari A; Allegro V; Saro R; Varrà GG; Pagura L; Rossi M; Lalario A; Longo F; Korcova R; Dal Ferro M; Perkan A; Dore F; Bussani R; De Sabbata GM; Zaja F; Merlo M; Sinagra G
    Front Cardiovasc Med; 2022; 9():1026440. PubMed ID: 36419501
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Characteristics and Clinical Outcomes of Patients Hospitalized for Acute Heart Failure Who Develop Atrial Fibrillation or Convert to Sinus Rhythm.
    Zandijk AJL; Boorsma EM; ter Maaten JM; Rienstra M; Voors AA
    J Card Fail; 2024 Jul; ():. PubMed ID: 39029616
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Enhancing knowledge and awareness of transthyretin cardiac amyloidosis and shared decision-making among cardiology team members in Colorado, USA via an online educational initiative.
    Ismailov RM; Lerut J; Aceña Á; Khasanova ZD
    Hosp Pract (1995); 2022 Feb; 50(1):37-41. PubMed ID: 34879213
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Atrial Fibrillation in the Elderly: The Role of Sub-Clinical Isolated Cardiac Amyloidosis.
    Krishnappa D; Dykoski R; Can I; Mbai M; Anand IS; Florea V; Chandrashekar YS; Li JM; Tholakanahalli VN
    Sci Rep; 2019 Nov; 9(1):16584. PubMed ID: 31719596
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Cardiogenic Shock Due to Atrial Arrhythmia as the Initial Presentation of Transthyretin Cardiac Amyloidosis.
    Schneider SM; Kochar K; Ruge M; Marek-Iannucci S; Datta T; Hajduczok A; Ullah W; Rajapreyar I; Brailovsky Y
    JACC Case Rep; 2022 Nov; 4(22):1490-1495. PubMed ID: 36444185
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Thromboembolic and Bleeding Events in Transthyretin Amyloidosis and Coagulation System Abnormalities: A Review.
    Napolitano A; De Michieli L; Sinigiani G; Berno T; Cipriani A; Spiezia L
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892778
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Atrial fibrillation in transthyretin amyloidotic cardiomyopathy: prevalence and echocardiographic predictors.
    Rodríguez MR; Spaccavento A; Diez M; Conde D; Burgos LM; Seia IM; Meretta A; Baranchuk A; Gupta S; Costabel JP
    Minerva Cardiol Angiol; 2024 Oct; ():. PubMed ID: 39352728
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure-Volume Analysis.
    Batra J; Rosenblum H; Defilippis EM; Griffin JM; Saith SE; Gamino D; Teruya S; Santos JL; Helmke S; Burkhoff D; Maurer MS
    J Card Fail; 2021 Jan; 27(1):67-74. PubMed ID: 32829019
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study.
    Westin O; Butt JH; Gustafsson F; Schou M; Salomo M; Køber L; Maurer M; Fosbøl EL
    JACC CardioOncol; 2021 Oct; 3(4):522-533. PubMed ID: 34729524
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Associations of Patients with Pericardial Effusion Secondary to Light-Chain or Transthyretin Amyloidosis- A Systematic Review.
    Javed N; Singh K; Shirah J; Vittorio TJ
    Curr Cardiol Rev; 2024; 20(4):e080324227805. PubMed ID: 38465427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.